Loading...
Supermax Corporation Berhad
SPMXF•PNK
Healthcare
Medical - Instruments & Supplies
$0.15
$0.00(0.00%)
Supermax Corporation Berhad (SPMXF) Financial Performance & Income Statement Overview
Review Supermax Corporation Berhad’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-21.30%
↓ 21.30%
Operating Income Growth
4.39%
↑ 4.39%
Net Income Growth
-24.67%
↓ 24.67%
Operating Cash Flow Growth
-212.19%
↓ 212.19%
Operating Margin
1.82%
↑ 1.82%
Gross Margin
71.06%
↑ 71.06%
Net Profit Margin
-27.43%
↓ 27.43%
ROE
-5.18%
↓ 5.18%
ROIC
0.34%
↑ 0.34%
Supermax Corporation Berhad (SPMXF) Income Statement & Financial Overview
Review Supermax Corporation Berhad's (SPMXF) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $198.79M | $224.65M | $179.64M | $143.01M |
| Cost of Revenue | $249.92M | $0.00 | $300.76M | $153.09M |
| Gross Profit | -$51.14M | $224.65M | -$121.12M | -$10.08M |
| Gross Profit Ratio | -$0.26 | $1.00 | -$0.67 | -$0.07 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $220.39M | $224.65M | $179.64M | $139.08M |
| Total Costs & Expenses | $220.39M | $224.65M | $179.64M | $153.09M |
| Interest Income | $19.78M | $0.00 | $0.00 | $0.00 |
| Interest Expense | $2.10M | $1.46M | $2.45M | $1.17M |
| Depreciation & Amortization | $15.57M | $0.00 | -$26.06M | $6.02M |
| EBITDA | $13.75M | -$80.54M | -$119.91M | $9.95M |
| EBITDA Ratio | $0.07 | -$0.36 | -$0.67 | $0.07 |
| Operating Income | -$21.60M | $0.00 | -$93.85M | -$10.08M |
| Operating Income Ratio | -$0.11 | $0.00 | -$0.52 | -$0.07 |
| Other Income/Expenses (Net) | $17.69M | -$81.99M | -$28.51M | $12.84M |
| Income Before Tax | -$3.91M | -$81.99M | -$122.36M | $2.76M |
| Income Before Tax Ratio | -$0.02 | -$0.36 | -$0.68 | $0.02 |
| Income Tax Expense | $2.17M | -$16.12M | $9.30M | $2.77M |
| Net Income | -$4.92M | -$64.63M | -$128.52M | -$686000.00 |
| Net Income Ratio | -$0.02 | -$0.29 | -$0.72 | -$0.005 |
| EPS | -$0.002 | -$0.03 | -$0.05 | -$0.00 |
| Diluted EPS | -$0.002 | -$0.03 | -$0.05 | -$0.00 |
| Weighted Avg Shares Outstanding | $3.06B | $2.56B | $2.57B | $2.58B |
| Weighted Avg Shares Outstanding (Diluted) | $3.06B | $2.56B | $2.57B | $2.58B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan